Latest Breaking News On - Company discuva platform - Page 1 : comparemela.com

Form 8-K Summit Therapeutics Inc For: Nov 03

Form 8-K Summit Therapeutics Inc For: Nov 03
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomHarvard universityUnited statesMaky zanganehRobertw dugganDave gancarzGlobal head of regulatory affairsTeam summitDrug development regulatory affairs at nektar therapeuticsPharmacyclics incSeasoned regulatory clinical research executive drSummit therapeutics incCompany discuva platformTherapeutics bolsters its boardSummit therapeuticsUrte gayko

Summit Therapeutics Bolsters Its Board of Directors with

Cambridge, Massachusetts, Nov. 03, 2021 (GLOBE NEWSWIRE) Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Dr. Urte Gayko, PhD, has been.

United kingdomHarvard universityUnited statesMaky zanganehRobertw dugganDave gancarzGlobal head of regulatory affairsTeam summitDrug development regulatory affairs at nektar therapeuticsPharmacyclics incSummit therapeutics incCompany discuva platformUrte gaykoSenior vice presidentDrug developmentRegulatory affairs

Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United kingdomHarvard universityUnited statesMaky zanganehRobertw dugganDave gancarzGlobal head of regulatory affairsTeam summitExchange commissionDrug development regulatory affairs at nektar therapeuticsPharmacyclics incSummit therapeutics incCompany discuva platformUrte gaykoSenior vice presidentDrug development

Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr Urte Gayko - Form 8-K

Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr. Urte Gayko Cambridge, Massachusetts - Summit. | November 3, 2021

United kingdomHarvard universityUnited statesMaky zanganehRobertw dugganDave gancarzGlobal head of regulatory affairsTeam summitDrug development regulatory affairs at nektar therapeuticsPharmacyclics incSeasoned regulatory clinical research executive drSummit therapeutics incCompany discuva platformSummit therapeutics bolsters its boardUrte gaykoSenior vice president

Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A Clark to Its Board of Directors

Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A Clark to Its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomKennetha clarkMaky zanganehWilson sonsini goodrich rosatiRobertw dugganTeam summitUniversity of texas school lawExchange commissionPulse biosciences incPharmacyclics incVanderbilt universitySummit therapeutics incCompany discuva platformWilson sonsini goodrichPalo altoPulse biosciences